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Abstract
Background and Aim: Excessive use of trypanocidal drugs can lead to cases of drug resistance. Multiple cases of resistance 
have been widely reported for drugs such as isometamidium chloride and diminazene aceturate. These cases deserve 
serious attention, especially in Indonesia, where the first case was recorded and where the molecular basis of trypanocidal 
drug resistance has never been evaluated. This study aimed to analyze the multidrug resistance protein (MRP) gene in 
Trypanosoma evansi isolates, sampled from Indonesia, by focusing on the phylogenetic relationship between these isolates 
and other Trypanosoma spp.
Materials and Methods: A total of 88 blood samples were drawn from buffaloes in the Ngawi district, Indonesia. Animals 
infected with T. evansi were detected through the microhematocrit technique and Giemsa blood smear methods. Positive 
blood samples were used to inoculate in male mice (Mus musculus BALB-C strain) as an animal model for culturing the 
T. evansi. The genomic DNA of the blood taken from the T. evansi-infected mice was used for polymerase chain reaction 
amplification, sequencing, and phylogenetic analysis.
Results: Two genes were analyzed; the first gene detected for T. evansi corresponded to Trypanosoma brucei with a 
homology of 99% and the second gene to Trypanosoma brucei gambiense, with a homology of 100%. These two genes of 
the MRP from T. evansi showed clear similarity to the MRPE and MRPA genes of the T. brucei ssp.
Conclusion: The MRP gene is conserved on the subspecies level of T. brucei. Only few point mutations were found between 
various sequences, which mean that the proteins have the same structure. This is important to treat the parasite with the 
appropriate drugs in the future.
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Introduction
Trypanosoma evansi has the widest host range 
among all the pathogenic trypanosomes and infects 
both domestic animals and wildlife throughout the 
world. T. evansi is the cause of the infectious multi-
species disease called surra [1]. The importance of 
controlling surra has been identified by the Indonesian 
government, and they have subsequently established 
surra as a strategic infectious animal disease in 2012. 
The prevention and the eradication of the disease are 
generally focused on two areas: Pathogen control and 
vector control [2]. The government implemented a 
treatment program using trypanocidal drugs such as 
isometamidium (Trypamedium®, Samorin®) and dimi-
nazene (Berenil®, Tryponil®) in an effort to control the 
disease [3].
It is important to note that the excessive use of try-
panocidal drugs can lead to resistance among T. evansi 
isolates. The resistance to trypanocidal drugs has been 
widely reported in several countries [3,4]. There are 
three commonly used trypanocidal drugs that can lead 
to drug resistance: Isometamidium chloride (ISM), 
diminazene aceturate, and homidium. There are an 
escalating number of cases showing an increase in 
resistance against these trypanocidal agents. Research 
by Tihon et al. [5] showed that continuous treatment 
with ISM will lead to changes in the adenosine tri-
phosphate-binding cassette (ABC) transporter coding 
gene as well as other membrane transporter proteins. 
The ABC transporters are one of the largest protein 
families present in organisms and have been found to 
play a critical role in multidrug resistance [6,7]. The 
multidrug resistance protein (MRP), a subfamily of 
the ABC transporters, might potentially be influenced 
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through continuous exposure to ISM [8,9]. However, 
at this stage, no member of this ubiquitous protein 
family has yet been described in T. evansi.
Cases of surra in Indonesia deserve particular 
attention since the first recorded case was in Indonesia. 
In addition, it would also be beneficial to further study 
cases of multidrug resistance in Trypanosoma to con-
tribute to the understanding of the roles of MRP in 
T. evansi. This study aimed to analyze the MRP gene 
in T. evansi isolates, sampled from Indonesia, by 
focusing on the phylogenetic relationship between 
these isolates and other Trypanosoma spp.
Materials and Methods
Ethical approval
All experimental protocols and animal work 
were approved by the Ethical Clearance Committee 
of the Veterinary Faculty, Gadjah Mada University, 
Indonesia (clearance number 0024/EC-FKH/
Int./2018), and conducted with strict adherence to the 
principles of laboratory animal care.
Trypanosome sample collection
In total, 88 blood samples (56 females and 
32 males) were drawn from buffaloes in the Ngawi 
district, Indonesia, and brought to Balai Besar 
Veteriner Wates. All 88 blood samples were ana-
lyzed using microhematocrit and Giemsa staining of 
blood smears to determine the presence of T. evansi 
in the blood samples. The microhematocrit centrifu-
gation technique method was done by taking blood 
from mice infected with microhematocrit capillaries 
and centrifuging it at 2555× g for 10 min; then, the 
Trypanosoma were observed in the white area, which 
is called the buffy coat. One positive sample was ran-
domly selected and processed as described in section 
2.4; 5 ml of the diluted solution was subsequently 
injected into the peritoneal cavity of 20 male mice 
(Mus musculus BALB-C strain), which were used as 
the animal model for the study.
Maintaining animal models
The 20 adult male mice had a weight range of 
25-30 g. These mice were obtained from the Animal 
House Research Center of Gadjah Mada, Indonesia. 
The mice were allowed to acclimatize to their envi-
ronment for 14 days in the parasitological laboratory 
of the veterinary faculty of the university, in which 
the experiment was conducted. The mice were housed 
in plastic cages under standard hygienic conditions 
with wood shavings as bedding which was changed 
weekly. The mice were kept at the ambient tempera-
ture of 24-26°C and relative humidity of 70-80%, with 
a 12 h/day light period. They were provided with rat 
pellets and water ad libitum.
Parasitic inoculation of mice
An infected blood sample (1 ml) was drawn 
from a donor mouse at peak parasitemia and diluted in 
4 ml physiological saline solution, and these dilutions 
were also used to maintain the samples. Subsequently, 
5 ml of the diluted blood sample was injected into the 
peritoneal cavity of healthy mice. One milliliter of 
the blood containing approximately 106 cells/ml was 
inoculated into each mouse at 30 mg body weight [5]. 
The parasitemia was monitored daily by preparing 
a wet mount which was then viewed under a light 
microscope. Mice in which a parasitemia of 105 cell/
blood slide was observed were identified, and blood 
was drawn through the retro-orbital sinus after which 
they were euthanized. Blood samples were stored at 
4°C to be used for DNA extraction.
DNA extraction
DNA was extracted from the mouse blood sam-
ples containing Trypanosoma using the DNeasy DNA 
extraction kit (Qiagen) according to the manufactur-
er’s instructions. Phosphate-buffered saline was added 
to 150 ml of the blood sample until a final volume of 
200 µl and mixed gently. Twenty microliter protein-
ase K was added to the solution, vortexed, and incu-
bated at 60°C for 5 min, during which time, the tube 
containing the solution was inverted every 2 min. To 
the solution, 200 µl absolute alcohol was added, and 
the sample was vortexed for 10 s. The total volume 
of the solution was transferred to a spin column and 
centrifuged at 14-16,000× g for 1 min. Following cen-
trifugation, an internal membrane was moved to the 
new collection column. To the DNA-binding column, 
400 µl of W1 buffer was added followed by centrif-
ugation at 14-16,000× g for 30 s. The DNA-binding 
column was washed by the addition of 600 µl wash 
buffer and centrifuged at 14-16,000× g for 3 min. The 
DNA was eluted by the addition of 100 µl buffer elu-
tion and recovered by centrifugation at 14-16,000× g 
for 1 min.
DNA amplification
Each polymerase chain reaction mixture was 
performed in a final volume of 50 µl and contained 
25 µl of 2× GoTaq Green polymerase Master Mix, 10 
µl DNA template extracted as described in section 2.5, 
1 µl genome-specific forward and reverse primers, and 
distilled water to the final volume. Subsequently, the 
tubes were placed into a thermal cycler and subjected 
to an initial denaturation at 94°C for 7 min, followed 
by 35 cycles of denaturation at 94°C for 30 s, primer 
annealing at 58°C for 30 s, and extension at 72°C for 
60 s. Following the last cycle, the reaction was kept 
at 72°C for 5 min to allow time for the completion of 
all the strands [10]. The primers used for the reaction 
were specific for the MRP gene of Trypanosoma bru-
cei F1 5’ CCTCACTTTGTGGCCGTATAA 3’, primer 
R1 5’ ATCCACAGCCTCCGTATTCTT 3’; primer 
F2 5’ AGATGAGTGATCAAGACTGGAAA 3’, 
primer R2 5’ ACCGGTTATACCACCATTA CTTT 3’.
DNA sequencing and phylogenetic analysis
The amplified DNA sequences were submitted 
for sequencing at the sequencing facility in First Base, 
Malaysia, and sequenced using the forward and reverse 
primers (section 2.6). The nucleotide sequences were 
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analyzed and compared with the MRP gene sequence 
of T. brucei as a positive control (GenBank accession 
number XM841956.1). Phylogenetic trees were con-
structed using maximum likelihood with the 2-param-
eter Kimura model of MEGA 7 software [11,12].
Results
Morphology
The morphology of the Trypanosoma isolates 
present in the buffaloes blood samples from Ngawi 
(East Java Province) matched that of T. evansi 
(Figure-1) as described by Desquesnes et al. [1].
DNA sequence analysis, variation, and nucleotide 
diversity
Results for the first T. evansi MRP gene showed 
99% similarity of query coverage to the T. brucei 
MRPA (TbMRPA, Tb927.8.2160). It was approved as 
an MRPA gene of T. evansi and named the T. evansi 
MRPA gene (TevMRPA). A subsequent analysis of the 
variation between TevMRPA and TbMRPA revealed 
the presence of several mutations in TevMRPA 
(Table-1). Two categories of mutations were pres-
ent; three instances of transition mutations and nine 
instances of transverse mutations. However, the 
nucleotide diversity between TevMRPA and TbMRPA 
was 1.3% indicating that the nucleotide variation was 
not significant.
The second T. evansi MRP gene that was sequenced 
showed 100% similarity to the Trypanosoma brucei 
gambiense MRPE gene (TgMRPE, XM 011774747.1). 
Confirming that, this gene was a MRPE gene from 
T. evansi, and it was named the T. evansi MRPE gene 
(TevMRPE). The subsequent analysis of the variation 
between TevMRPE and TgMRPE revealed only one 
transition mutation at 766 bp where adenosine was 
substituted for guanine in the TevMRPE nucleotide 
sequence. Further analysis showed that this mutation 
did not lead to any change in amino acid sequence 
of TevMRPE. The nucleotide diversity between 
TevMRPE and TgMRPE was 0.07%, which was not 
significant.
Inter- and intra-species diversity with phylogenetic 
analysis
The TevMRP partial genes were compared to 
several intraspecies and interspecies the MRP family 
genes such as MRPA, MRPE, and P-gp gene using 
discontinuous megablast results. The phylogenetic 
tree (Figure-2) showed that the TevMRPA gene had 
a short genetic distance to TbMRPA (1.4%) and a 
large genetic distance to Trypanosoma vivax MRPA 
(TvxMRPA) and Leishmania mexicana P-gp (LmPgp), 
47% and 50%, respectively (Table-2). The maximum 
likelihood tree of TevMRPA, constructed with the 
Kimura 2-parameter method showed that TevMRPA 
was included in a clade along with TbMRPA, while the 
TvxMRPA and the LmPgp were included in different 
clades (Figure-2). The phylogenetic tree for TevMRPE 
(Figure-3) showed that the branch between TevMRPE, 
TgMRPE (0.1%), and TbMRPE (0.3%) was short, and 
there was a large genetic distance of 72% between 
TevMRPE and Leishmania tarentolae P-gp (LtPgp) 
(Table-3). In addition, it was found that TevMRPE, 
TbMRPE, and TgMRPE were in one clade, whereas 
LtPgp were altogether in a different clade (Figure-3).
Discussion
There have been several cases of T. evansi drug 
resistance reported in Indonesia [13]. Such cases of 
resistance to trypanocidal drugs can be a result of 
mutations in the gene responsible for the transporter 
proteins in cell membranes and organelles [14,15]. 
This was investigated by Campos et al. [16], in which 
they exposed Trypanosoma cruzi to Benznidazole. 
In their study, they found that continuous exposure 
of T. cruzi to Benznidazole resulted in mutations in 
a novel ABCG-like transporter coding gene, which 
caused an almost 2-2.6-fold increase in the resistance 
of T. cruzi to Benznidazole [16,17]. Drug resistance 
that results from mutations may lead to the transporter 
proteins selectively transporting substances across 
the cell membrane preventing the trypanocidal drugs 
Table-1: Comparison of nucleotide variations and types of mutations between TevMRPA and TbMRPA.
Species Nucleotide sequence number
51 72 153 193 311 428 456 583 792 777 860 903
TevMRPA gene A G G A G G A T T T A A
TbMRPA gene G A A C A A G A C G G G
Type of mutation TS TS TS TV TS TS TS TV TS TV TS TS
*Description: TV and TS. TV=Transverse mutation, TS=Transition mutation, TevMRPA=Trypanosoma evansi MRPA gene, 
TbMRPA=Trypanosoma brucei MRPA
Figure-1: Morphology of Trypanosoma evansi with Giemsa 
staining viewed under a light microscope (original 400×).
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from entering the cell. Based on the role of MRP in 
Trypanosoma spp., it was of interest to specifically 
investigate MRP in T. evansi [5,9].
Research by Shahi et al. [18] showed that over-
expression of the MRPE gene would cause a 2-3-fold 
increase in suramin drug resistance, followed by an 
increase in the efflux work by MRPE. Suramin is 
a medication used to treat African Trypanosoma. 
Suramin is a highly charged molecule at physiolog-
ical pH and, therefore, unable to permeate the cell 
membrane by passive diffusion. It is administered 
by intravenous injection. The mechanism of action 
for suramin remains unclear; however, it is thought 
that parasites are able to selectively uptake sura-
min through receptor-mediated endocytosis of drugs 
bound to low-density lipoproteins and, to a lesser 
extent, other serum proteins. Once inside parasites, 
suramin combines with proteins, especially trypano-
somal glycolytic enzymes, to inhibit energy metabo-
lism [19]. It has been reported that overexpression of 
T. cruzi MRPA, also known as the ABCC transporter, 
was related to chemotherapy failure [20].
Nucleotide changes in the TevMRPA gene as 
compared to the TbMRPA gene impact the translation 
of the sequences to amino acids; there were six amino 
acid changes observed between these two genes. Such 
a change could possibly alter the protein structure and 
function; however, there are certain instances where 
such a mutation does not have an impact on the amino 
acid sequence, for example, cases where isoleucine is 
changed to leucine. An example of amino acid alter-
ations that could give rise to differences in the func-
tion of the protein is changed in arginine. Arginine, 
which is a component of charged proteins (located in 
the side chains of salt bridges) changed to histidine 
would lead the different function of the protein, which 
is usually histidine, binds the hydrogen and functions 
as proton donor or acceptor [21]. Another example of 
such a case is the change from isoleucine to methi-
onine, which would change the structure of the protein 
itself [22]. Research by Mathieu et al. [23] showed 
that the increasing number of arginine and lysine 
amino acids in the transporter proteins is essential 
for T. brucei. On the other hand, the TevMRPE gene 
has only one nucleotide difference when compared 
to TgMRPE. In addition, there is no change in amino 
acids, indicating that the MRPE gene is conserved at 
the subspecies level in T. brucei.
The results of the genetic distance and phylog-
eny analysis showed that the putative TevMRP gene is 
always in one clade with the MRP gene from T. brucei 
spp. Moreover, T. evansi and Trypanosoma gambiense 
most likely evolved from T. brucei spp.; hence, T. evansi 
is also called T. brucei evansi. There are several sub-
species in T. brucei, such as T. brucei, T. brucei gam-
biense, T. brucei evansi, and T. brucei equiperdum [1]. 
Wen et al. [24] reported that T. evansi and T. equiper-
dum are subspecies of T. brucei. The evolution is based 
on the mitochondrial/kDNA, which is the distinguish-
ing factor between the various T. brucei. The T. brucei 
has hundreds of minicircles, while T. equiperdum and 
T. evansi only have one minicircle [25].
Conclusion
The obtained genes were putative as TevMRPA 
and TevMRPE. In this case, the coding gene of the 
MRP was conserved on the subspecies level; only 
a few point mutations were found between various 
sequences, which mean that the proteins have the same 
structure. Future research can be conducted on further 
understanding of the drug resistance mechanism.
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Table-2: Genetic distance of the Trypanosoma evansi 
MRPA gene compared with intraspecies and interspecies.
Species 1 2 3
Trypanosoma evansi MRPA
Trypanosoma brucei MRPA 0.014
Trypanosoma vivax MRPA 0.470 0.467
Leishmania mexicana P-gp 0.504 0.490 0.542
Table-3: Genetic distance of the Trypanosoma evansi 
MRPE gene compared with intraspecies and interspecies.
Species 1 2 3
Trypanosoma evansi MRPE
Trypanosoma brucei MRPE 0.003
Trypanosoma brucei gambiense MRPE 0.001 0.001
Leishmania tarentolae P-gp 0.725 0.725 0.721
Figure-2: Phylogenetic tree of the Trypanosoma evansi 
MRPA gene (Trypanosoma evansi MRPA) gene using 
maximum likelihood with the 2-parameter Kimura 
model. The phylogenetic tree showed that TevMRPA and 
Trypanosoma brucei MRPA are in one clade.
Figure-3: The Trypanosoma evansi MRPE gene (TevMRPE) 
gene phylogenetic tree uses the construct maximum 
likelihood tree with the 2-parameter Kimura model. The 
phylogenetic tree showed that Trypanosoma MRPE, 
Trypanosoma gambiense MRPE, and Trypanosoma brucei 
MRPE are in one clade.
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